IndraLab

Statements



reach
"EGCG also abrogated the nicotine induced activation of AP-1 subunits c-fos and c-jun."

reach
"Recently, EGCG has been shown to inhibit MAP kinase pathway and activator protein-1 (AP-1) activity in human colon cancer cells."

reach
"The binding of EGCG with Arg17 in the WW domain prevented the binding of c-Jun, a well-known Pin1 substrate."

reach
"Further experiments demonstrated that EGCG reduced the transcriptional activity of activator protein-1 (AP-1) and nuclear factor kappaB (NF-kappaB), two important nuclear transcription factors that are involved in MMP-9 expression."

reach
"EGCG inhibits nuclear factor-kbeta and activator protein 1 in dermal fibroblasts."

reach
"Furthermore, we report for the first time that EGCG blocks the activation of the pro-apoptotic proteins c-JUN, P53, and PUMA [54]; all indirect/direct players in the mitochondria depolarization, and subsequent releasing of apoptogenic proteins (e.g., cytochrome c) which ended up in the activation of CASP-3 in mutant neurons."
| PMC

reach
"EGCG decreased transcription activity of Jun protein after induction by UVA."

reach
"EGCG inhibited transcription factor AP-1, binding to DNA."

reach
"At the same dose range that inhibited cell transformation, EGCG and theaflavins inhibited activator protein-1 (AP-1) activation."

reach
"We found that EGCG (50 muM) significantly inhibited the aggregation of (i)sAPPbetaf, blocked p-TAU, increased incrementPsim, decreased oxidation of DJ-1 at residue Cys106-SH, and inhibited the activation of transcription factor c-JUN and P53, PUMA, and CASPASE-3 in mutant ChLNs compared to WT."
| PMC

sparser
"EGCG inhibits nuclear factor-kβ and activator protein 1 in dermal fibroblasts."

reach
"EGCG has been shown to inhibit NF-kappaB activity, MAPK pathway, activator protein-1 (AP-1) activity, and EGFR mediated downstream signaling pathways, etc.."

reach
"EGCG inhibits AP-1, JNK, c-Jun and cyclinD1 which are key targets on AP-1 signal transduction pathway."

reach
"EGCG could also inactivate c-Jun, NF-kappaB, ERK1/2, and p38 signaling, resulting in decreased expression of MMP-2 and MMP-9 in PCa cells [XREF_BIBR]."

reach
"In particular, EGCG inhibited tumor promoter induced activator protein-1, signal transducers and activators of transcription, phosphatidylinositol 3-kinase/Akt, and nuclear factor-kappaB activation."

reach
"Reporter assays indicated that both EGCG and Poly E inhibited the transcriptional activity of the activator protein 1 (AP-1), c-fos, nuclear factor kappaB, and cyclin D1 promoters."

reach
"However, EGCG significantly reduced c-JUN (Figure 3A,B), P53 (Figure 3A,C), PUMA (Figure 3A,D), and CASP-3 (Figure 3A,E) in PSEN1 E280A neurons compared to treated WT ChLNs cells."
| PMC

reach
"EGCG caused a decreased abundance of cyclin D1 and decreased activator protein 1 or NFκB promoter activity induced by a phorbol ester in cells expressing Pin1."

sparser
"EGCG inhibits AP-1, JNK, c-Jun and cyclinD1 which are key targets on AP-1 signal transduction pathway."

reach
"The binding of EGCG with Arg17 in the domain (1–39) prevented the binding of substrate c-Jun."

reach
"These intermediate pathways are involved in transformation, differentiation, and cell proliferation but, more importantly, EGCg also inhibited activator protein 1 (AP-1) function which has been associ[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"